Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
35.03%
14:46

Could be very worthwhile Investment >20% year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€208.80
07.09.22
€300.00
31.12.24
14.94%
16:15

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
-2.01%
12.08.24

Could be very worthwhile Investment >20% year
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.60
07.09.22
€50.00
31.12.24
-5.32%
12.08.24

Could be very worthwhile Investment >20% year
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-8.97%
16:24

Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€196.52
08.01.22
€915.00
14.01.27
118.04%
15:39

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.48
30.09.16
€98.00
08.09.26
19.90%
15:47

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued